Danish biopharma giant Novo Nordisk (NOV: N) is breaking new ground with its GLP-1 agonist semaglutide, as a small mid-stage ...
The former glamour model, 45, has gone under the knife for a long list of procedures, most recently jetting to Turkey to have ...
Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...
An advert for the company’s power stretch denim leggings has been banned by the Advertising Standards Agency (ASA) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback